This opportunity involves the purchase and delivery of twenty Bordetella-free baboons to support research on pertussis disease and vaccine effectiveness. The baboon model, developed by the FDA’s Center for Biologics Evaluation and Research, is the only animal model that replicates human pertussis symptoms. The study aims to refine this model to evaluate differences between acellular and whole cell pertussis vaccines. Performance of services will be at the FDA’s Center for Biologics Evaluation and Research. A timeline of 6/29/2026 is noted, but no budget amount is specified.